Cargando…
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling
BACKGROUND: Tumor treating fields (TTF) is the latest treatment for GBM. Circular RNA (circRNA) has been demonstrated to play critical roles in tumorigenesis. However, the molecular mechanism of TTF remained largely unknown and the role of circRNA in TTF was not reported. The aim of this study was t...
Autores principales: | Xu, Shengchao, Luo, Chengke, Chen, Dikang, Tang, Lu, Cheng, Quan, Chen, Ling, Liu, Zhixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021944/ https://www.ncbi.nlm.nih.gov/pubmed/36932454 http://dx.doi.org/10.1186/s13046-023-02642-z |
Ejemplares similares
-
CircMMD_007 promotes oncogenic effects in the progression of lung adenocarcinoma through microRNA-197-3p/protein tyrosine phosphatase non-receptor type 9 axis
por: Zhu, Lihuan, et al.
Publicado: (2022) -
Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022) -
Correction: Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022) -
FUBP1 promotes colorectal cancer stemness and metastasis via DVL1‐mediated activation of Wnt/β‐catenin signaling
por: Yin, Haofan, et al.
Publicado: (2021) -
FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells
por: Zheng, Ying, et al.
Publicado: (2020)